The National Immunisation Advisory Committee (NIAC) has issued updated evidence-based recommendations to the Department of Health on COVID-19 vacination for those aged 12-15 years.
Read more
Prof Karina Butler, Chair of National Immunisation Advisory Committee (NIAC), will explain NIAC's work in providing evidence-based advice to the Chief Medical Officer on immunisation at the Joint Committee on Health which meets at 3:30pm today, 20 April 2021.
Read more
The National Immunisation Advisory Committee (NIAC) has issued revised advice to the Department of Health on the use of the AstraZeneca COVID-19 vaccine in light of the outcome of the recent investigation by the European Medicines Agency. The EMA has added unusual clotting events with low platelet counts as very rare side effects to the vaccine product information. These rare events are estimated to occur between 4 and 10 in every 1 million people, one of whom may die.
Read more
The National Immunisation Advisory Committee (NIAC) notes the finding from the European Medicines Agency regarding the AstraZeneca vaccine and statements from the UK. The EMA has advised of finding a possible link between the AstraZeneca Covid-19 vaccine and rare blood clotting issues in adults who had received the vaccine. The regulatory agency concluded that the overall benefits of this highly effective vaccine in protecting recipients from severe COVID-19 disease, hospitalisation and death outweigh the risks of this very rare event. NIAC’s current advice regarding the AstraZeneca vaccine still applies.
Read more
The National Immunisation Advisory Committee (NIAC) has issued updated evidence-based recommendations to the Department of Health on prioritisation groups for COVID-19 vaccination.
Read more
The National Immunisation Advisory Committee (NIAC) is recommending resumption of the COVID-19 vaccine AstraZeneca. NIAC strongly encourages everyone to take up COVID-19 vaccination when offered.
Read more
The National Immunisation Advisory Committee (NIAC) has today (Sunday, 14 March 2021) recommended the temporary deferral of the administration of the COVID-19 Vaccine AstraZeneca®.
Read more
National Immunisation Advisory Committee (NIAC) issues new guidance on prioritisation groups for COVID-19 vaccination for those aged 65 and older and those aged 16 to 64 with medical conditions that put them at high risk of severe disease.
Read more
The National Immunisation Advisory Committee (NIAC) has issued recommendations on the use of the COVID-19 Vaccine AstraZeneca® in older adults.
Read more
Professor Karina Butler, Chair of the National Immunisation Advisory Committee, was invited to contribute to the discussions on the rollout of the COVID-19 vaccine at the Joint Oireachtas Committee on Health.
Read more